Nektar Therapeutics (NKTR) Construction in Progress (2010 - 2024)

Nektar Therapeutics' Construction in Progress history runs 15 years deep, the most recent figure standing at $245000.0 for Q4 2024.

• In Q4 2024, Construction in Progress fell 66.85% year-over-year to $245000.0; the TTM figure through Dec 2024 stood at $245000.0 (down 66.85% YoY), while the FY2024 annual figure was $245000.0, down 66.85% from the prior year.
• Construction in Progress was $245000.0 for Q4 2024 at Nektar Therapeutics, up from $138000.0 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $7.2 million in Q4 2021 to a low of $138000.0 in Q3 2024.
• Historically, Construction in Progress has averaged $1.8 million across 5 years, with a median of $731500.0 in 2023.
• Biggest YoY gain for Construction in Progress was 57.05% in 2024; the steepest drop was 71.72% in 2024.
• A 5-year view of Construction in Progress shows it stood at $4.7 million in 2020, then soared by 52.4% to $7.2 million in 2021, then plunged by 64.68% to $2.5 million in 2022, then slumped by 70.79% to $739000.0 in 2023, then slumped by 66.85% to $245000.0 in 2024.
• The last three Construction in Progress figures came in at $245000.0 (Q4 2024), $138000.0 (Q3 2024), and $724000.0 (Q2 2024), per Business Quant data.